Important NIH, FDA and AHRQ Notices

Dear Colleagues:

The following Notices may be of interest to faculty and researchers. Note that some Notices have been summarized for your convenience.  Please review and forward to faculty, researchers and others, as appropriate.

Questions regarding these notices should be directed to your assigned Contract and Grant Officer. 

  • Notice of Fiscal Policies in Effect for FY 2019
    (NOT-OD-19-031) National Institutes of Health

This notice provides guidance about the NIH fiscal Operations for FY 2019, implements the DOL, DHHS and Education Appropriations Act for 2019, and provides specific information about the fiscal policies instituted in FY 2019.  See notice for additional information.   

  • Ruth L. Kirschstein National Research Service Award (NRSA) Stipends, Tuition/Fees and Other Budgetary Levels Effective for Fiscal Year 2019
    (NOT-OD-19-036) National Institutes of Health

This Notice supersedes establishes new stipend levels for fiscal year (FY) 2019 Kirschstein-NRSA awards for undergraduate, predoctoral, and postdoctoral trainees and fellows.  See full notice for stipend levels.

  • Notice of Correction for Submission of Certification Letters for Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research
    (NOT-OD-19-039) National Institutes of Health

This Notice informs prospective applicants that consistent with prior instructions, applications submitted for Ruth L. Kirschstein National Research Service Award Individual Predoctoral Fellowship to Promote Diversity in Health Related Research (F31 – Diversity; PA-18-666) are required to attach a certification letter.  See full notice for additional information.

  • Notice of Extension of Expiration Date for PAR-16-070 NIDCR Small Research Grants for Data Analysis and Statistical Methodology Applied to Genome-wide Data (R03)
    (NOT-DE-18-030)
    National Institute of Dental and Craniofacial Research
  • Notice to Update Certificates of Confidentiality Terms and Conditions on all FDA Funding Opportunity Announcements and Grant Awards
    (NOT-FD-19-002)
    Food and Drug Administration

This notice is to inform all FDA applicants and awardees that the terms below regarding Certificates of Confidentiality – 42 U.S.C. 241(d) will be incorporated for all active FDA Funding Opportunity Announcements and awards effective October 1, 2018. This condition requires all awardees to comply with all requirements to protect the confidentiality of identifiable, sensitive information that is collected or used in biomedical, behavioral, clinical, or other research (including research on mental health and research on the use and effect of alcohol and other psychoactive drugs) funded wholly or in part by the Federal Government.  See notice for additional information.

  • REMINDER – Expiring Funds Alert to AHRQ Grant Recipients who Received Multi-Year Funded Awards
    (NOT-HS-19-002)
    Agency for Healthcare Research and Quality

See full notice for detailed information.

  • Reminder to AHRQ Grantees that FY2014 Funds will Expire on September 30, 2019
    (NOT-HS-19-003)
    Agency for Healthcare Research and Quality

See full notice for detailed information.

Sandra M. Stevens

Associate Director, Sponsored Projects

 

Sponsored Projects Administration

Office of Research

University of California, Irvine

141 Innovation, Suite 250
Irvine, CA 92617-3213

PH:  (949) 824-4928

Fax: (949) 824-2094

E-mail:     

http://www.research.uci.edu/

image001-4.png

* Sign up for the CG News listserv by sending a blank email to: .

The Office of Research will be closed for the UCI winter administrative recess from December 24, 2018 through January 1, 2019.  For guidance regarding funding opportunities with submission deadlines during the break, contact yourContract and Grant Officer.

Share